Saventic Information

Saventic Health develops AI-powered platforms to accelerate rare disease diagnosis and improve patient outcomes worldwide. - AI-powered rare disease diagnosis: Our advanced algorithms analyze electronic health records (EHR) to identify potential rare diseases earlier and with greater accuracy. - Valuable clinical insights: We equip clinicians with actionable data, streamlining decision-making and reducing diagnostic delays. - Global presence: We operate in Brazil, Canada, Colombia, Germany, Panama, Poland, and Taiwan, driving impact across healthcare systems worldwide. - Patient-centered innovation: Committed to improving patient outcomes, we continuously refine our platforms to better serve healthcare providers and their patients. Current Rare Diseases algorithms available in our portfolio: - Fabry Disease - Gaucher Disease - Hereditary Angioedema (HAE) - Castleman Disease - Niemann-Pick (ASMD) - Mucopolysaccharidosis (MPS) - Cutaneous T-cell Lymphoma (CTCL) - Hypophosphatasia (HPP) - Primary Immunodeficiency (PID) - Lysosomal Acid Lipase Deficiency (LAL-D) - Paroxysmal Nocturnal Hemoglobinuria (PNH) - Myelodysplastic syndromes (MDS) - Amyloidosis We also develop tailor-made algorithms for different rare medical conditions. Learn more about our services on our website.